AR038854A1 - Derivados funcionales de la pentraxina larga ptx3 para la preparacion de una vacuna autologa para el tratamiento de tumores - Google Patents

Derivados funcionales de la pentraxina larga ptx3 para la preparacion de una vacuna autologa para el tratamiento de tumores

Info

Publication number
AR038854A1
AR038854A1 ARP030100642A ARP030100642A AR038854A1 AR 038854 A1 AR038854 A1 AR 038854A1 AR P030100642 A ARP030100642 A AR P030100642A AR P030100642 A ARP030100642 A AR P030100642A AR 038854 A1 AR038854 A1 AR 038854A1
Authority
AR
Argentina
Prior art keywords
preparation
functional derivatives
tumor treatment
ptx3
automatic vaccine
Prior art date
Application number
ARP030100642A
Other languages
English (en)
Spanish (es)
Inventor
Santis Rita De
Giovanni Salvatori
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of AR038854A1 publication Critical patent/AR038854A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ARP030100642A 2002-02-28 2003-02-27 Derivados funcionales de la pentraxina larga ptx3 para la preparacion de una vacuna autologa para el tratamiento de tumores AR038854A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002RM000109A ITRM20020109A1 (it) 2002-02-28 2002-02-28 Derivati funzionali della pentraxina lunga ptx3 per preparare un vaccino autologo per la cura dei tumori.

Publications (1)

Publication Number Publication Date
AR038854A1 true AR038854A1 (es) 2005-01-26

Family

ID=11456119

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100642A AR038854A1 (es) 2002-02-28 2003-02-27 Derivados funcionales de la pentraxina larga ptx3 para la preparacion de una vacuna autologa para el tratamiento de tumores

Country Status (12)

Country Link
US (1) US20090110666A1 (https=)
EP (1) EP1478661A2 (https=)
JP (1) JP2005538690A (https=)
KR (1) KR20040099291A (https=)
AR (1) AR038854A1 (https=)
AU (1) AU2003214645A1 (https=)
CA (1) CA2475526A1 (https=)
IT (1) ITRM20020109A1 (https=)
MX (1) MXPA04008217A (https=)
PL (1) PL372719A1 (https=)
TW (1) TWI293958B (https=)
WO (1) WO2003072603A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20040858A1 (it) 2004-04-29 2004-07-29 Farma Dev S R L Anticorpi monoclonali ibridomi metodo migliorato per determinare la proteina ptx3 e kit per detta determinazione
ITRM20040489A1 (it) * 2004-10-08 2005-01-08 Sigma Tau Ind Farmaceuti Pentraxina lunga ptx3 deglicosilata o desialidata.
JP5427415B2 (ja) * 2006-01-24 2014-02-26 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ Ｆｇｆ２結合性ペプチドおよびそれらの使用
US9226960B2 (en) 2010-04-16 2016-01-05 Andrew B. Bush FGF modulation of in vivo antibody production and humoral immunity
US8435525B1 (en) * 2010-04-16 2013-05-07 Andrew B. Bush FGF modulation of in vivo antibody production and humoral immunity
TWI531375B (zh) 2015-05-29 2016-05-01 國立成功大學 抑制癌細胞活性之短肽治療劑及含此之醫藥組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849478A (en) * 1986-08-14 1998-12-15 Cashman; Daniel P. Blocked-polymerase polynucleotide immunoassay method and kit
US5290551A (en) * 1990-05-08 1994-03-01 Thomas Jefferson University Treatment of melanoma with a vaccine comprising irradiated autologous melanoma tumor cells conjugated to a hapten
IT1298487B1 (it) * 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
IT1317927B1 (it) * 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie autoimmuni.
IT1317930B1 (it) * 2000-11-08 2003-07-15 Sigma Tau Ind Farmaceuti Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patalogie associate ad una alterata attivazione
US20020122820A1 (en) * 2001-01-16 2002-09-05 Hildebrand William H. Soluble MHC artificial antigen presenting cells
US20040198655A1 (en) * 2001-08-03 2004-10-07 Alberto Mantovani Use of long pentraxin ptx3 for treating female infertility
US7041648B2 (en) * 2001-08-03 2006-05-09 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compositions and methods for treating female fertility
ITRM20020191A1 (it) * 2002-04-08 2003-10-08 Sigma Tau Ind Farmaceuti Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie tumorali associate ad una alterata att
US20040137544A1 (en) * 2002-10-31 2004-07-15 Roberto Latini PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies
ITRM20030596A1 (it) * 2003-12-23 2005-06-24 Sigma Tau Ind Farmaceuti Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3.
US20070023879A1 (en) * 2005-07-29 2007-02-01 Vinayak Pandey Single unit heat sink, voltage regulator, and package solution for an integrated circuit

Also Published As

Publication number Publication date
PL372719A1 (en) 2005-07-25
TWI293958B (en) 2008-03-01
ITRM20020109A1 (it) 2003-08-28
ITRM20020109A0 (it) 2002-02-28
WO2003072603A2 (en) 2003-09-04
AU2003214645A1 (en) 2003-09-09
WO2003072603A3 (en) 2004-03-18
AU2003214645A8 (en) 2003-09-09
WO2003072603A9 (en) 2004-10-07
MXPA04008217A (es) 2004-11-26
TW200303755A (en) 2003-09-16
JP2005538690A (ja) 2005-12-22
US20090110666A1 (en) 2009-04-30
CA2475526A1 (en) 2003-09-04
KR20040099291A (ko) 2004-11-26
EP1478661A2 (en) 2004-11-24

Similar Documents

Publication Publication Date Title
CL2022003788A1 (es) Moléculas de unión contra bcma y usos de las mismas
CY1124632T1 (el) Προϊοντα συζευξης αναλογων cc-1065 και διλειτουργικοι συνδετες
AU2018236742B2 (en) Compositions of adenosine deaminase-2 (ada2), variants thereof and methods of using same
MX2020005477A (es) Inmunoterapias con el uso de células efectoras potenciadas derivadas de ipsc.
MX2017008817A (es) Composiciones y metodos para la glicosilacion de proteinas.
CL2008001258A1 (es) Kit de vacuna que comprende al menos nueve conjugados de sacaridos de antgenos hb o hib, donde al menos 2-7 son con la proteina transportadora crm, siendo dicho kit adecuado para usar en su calendario de inmunizacion primaria; vacuna combinada adecuada para la inmunizacion primaria.
BR112021022514A2 (pt) Conjugados de anticorpo e fármaco
BR112019011450A2 (pt) células naturais killer modificadas e uso das mesmas
BR112018071026A2 (pt) macromoléculas fotoativas e usos das mesmas
AR112015A1 (es) Composiciones sólidas para administración oral
AR066042A1 (es) Moleculas y metodos para modular la proteina convertasa-subtilisina /quexina tipo 9 (pcsk9)
ECSP10010548A (es) Composiciones y metodos de preparacion y uso de las mismas
AR078601A1 (es) Composiciones inmunogenicas de antigenos de staphylococcus aureus
BR112016024363A2 (pt) conjugado de anticorpo-fármaco e seu uso para tratamento de câncer
MX2012002163A (es) Agentes novedosos y usos de los mismos.
CR9558A (es) Formulaciones de quinina
BRPI0819092A2 (pt) Evolução direcionada usando proteínas que compreendem aminoácidos não naturais.
EA200900738A1 (ru) Слитые белки, содержащие антигены отторжения опухоли ny-eso-1 и lage-1
AR068419A1 (es) Cepas de mycoplasma atenuadas vivas
NO20062709L (no) Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
WO2011156690A3 (en) Methods for the development of vaccines based on oligosaccharide-oligonucleotide conjugates
BR112019007365A2 (pt) métodos e composições para imunoterapia com tusc2
EP4252852A3 (en) Methods and materials for treating cancer
AR038854A1 (es) Derivados funcionales de la pentraxina larga ptx3 para la preparacion de una vacuna autologa para el tratamiento de tumores
ES2459204T8 (es) Procedimiento para pegar piedras semipreciosas con parte posterior que converge en punta sobre cuero

Legal Events

Date Code Title Description
FB Suspension of granting procedure